Advicenne Reports its Full-Year Financial Results to December 31, 2020 and Confirms its 2021 Outlook

April 28, 2021

Paris, France, April 28, 2021 – 11:30 pm CEST – Advicenne (Euronext: ADVIC), a French company specialized in the development of therapeutic products adapted to children and adults for treating nephrological and neurological orphan diseases, today reported its 2020 financial results.